Eimear Dolan, Bryan Saunders, Roger Charles Harris, Jose Eduardo Pereira Wilken Bicudo, David John Bishop, Craig Sale, Bruno Gualano The Intriguing Role of Histamine in Exercise Responses
Purpose-built for physicians GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity Key takeaways: Individuals who took GLP-1 receptor agonists for type 2 diabetes exhibited reduced risk for thrombosis
Notably, one study included in the meta-analysis, with a follow-up period of at least 2 years, showed that GLP-1 RAs were associated with a lower risk of MAKEs, and protocol biopsies results indicated that GLP-1 RAs may promote tubular cell regeneration in the kidney graft [59]
Xavier Collazo, a DPT specialising in sports performance and rehabilitation at Tampa Bay Performance Physical Therapy, emphasises that the benefits of GLP-1 drugs must be carefully balanced against the potential risks, particularly for non-obese and non-diabetic athletes
Not because it is perfect, but because it is proven